| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |